YH002

· Eucure (Beijing) Biopharma Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YH002, covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess YH002 in Combination with YH001 in Subjects with Advanced Solid Tumors [Phase 1]